UroLift® treatment is a modern, minimally invasive procedure designed to treat Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate. It offers relief from urinary symptoms without the need for traditional surgery, making it a safer and more comfortable option for many patients.
During the procedure, small implants are placed to gently lift and hold the enlarged prostate tissue away from the urethra. This helps open the urinary passage, allowing urine to flow more freely. Unlike other treatments, UroLift does not involve cutting, heating, or removing prostate tissue.
Because it is minimally invasive, UroLift typically requires less recovery time and can often be performed as a day-care procedure. Most patients experience quick symptom relief and can return to normal activities sooner, while also preserving normal sexual function.
No cutting or removal of tissue; performed in a clinic without hospital stay.
One of the biggest advantages of UroLift is that it is a minimally invasive procedure. Unlike traditional surgeries such as TURP, it does not involve cutting, heating, or removing prostate tissue. Instead, small implants are placed to gently lift and hold the enlarged prostate tissue away from the urethra, improving urine flow. Because there is no tissue removal, the risk of complications is lower, and the procedure can be performed in a clinic setting without the need for hospitalization.
Most men resume normal activities within 2–3 days, compared to weeks for traditional surgery.
UroLift is its quick recovery time compared to traditional prostate surgeries. Because the procedure doesn’t involve cutting or removing tissue, patients usually experience less pain and fewer complications. Most men are able to return to their normal routines within just two to three days, which is a significant improvement over the weeks of downtime often required after TURP or laser surgery.
Unlike TURP, UroLift does not cause retrograde ejaculation or erectile dysfunction.
A major concern for men undergoing prostate surgery is the risk of losing sexual function, particularly retrograde ejaculation or erectile dysfunction. Traditional procedures like TURP often damage nerves or remove tissue in ways that interfere with sexual performance. UroLift avoids this problem because it does not cut, heat, or remove prostate tissue. Instead, it uses small implants to gently hold the prostate open, leaving surrounding structures intact.
Safer for older patients or those with health risks, avoiding complications of general anesthesia.
Another advantage of UroLift is that it can be performed under local anesthesia, rather than requiring general anesthesia. This means patients remain awake but comfortable during the procedure, avoiding the risks associated with being fully sedated. For older men or those with existing health conditions, this greatly reduces complications and makes the treatment safer compared to traditional surgeries that often demand general anesthesia.
Clinical studies show 85–90% of men report improved urine flow and reduced symptoms within weeks.
Clinical studies have consistently shown that UroLift provides reliable and lasting relief for men with moderate BPH symptoms. By mechanically opening the urethra with small implants, it improves urine flow and reduces issues like frequent urination, weak stream, and incomplete bladder emptying. Within just a few weeks, most patients report noticeable improvements in their quality of life, with reduced discomfort and better bladder control.
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH), designed to relieve urinary symptoms by lifting and holding enlarged prostate tissue away from the urethra without cutting or removing tissue. It offers quick recovery and preserves sexual function, but may not be suitable for very large prostates or severe cases.
Procedure: A urologist inserts small permanent implants through the urethra to hold prostate tissue open.
Duration: Usually completed in 20–30 minutes under local anesthesia.
Goal: Improve urine flow and reduce symptoms like frequent urination, weak stream, and incomplete bladder emptying.
Dr. Venkatesh Kumar is a highly motivated and compassionate board certified Urologist, Andrologist & Uro-Oncologist in Noida. He has over 10 years of experience in Urology and has been trained in Indraprastha Apollo Hospital, New Delhi, India’s first JCI accredited 750 bedded superspeciality hospital.
